MedPath

REVBIO - SERVICOS EM SANIDADE E NUTRICAO VEGETAL LTDA

🇧🇷Brazil
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:1
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

A Pilot Clinical Study to Evidence Improved Cranial Flap Fixation with a Bioresorbable Bone Adhesive

Not Applicable
Recruiting
Conditions
Craniotomy
First Posted Date
2025-01-17
Last Posted Date
2025-03-11
Lead Sponsor
RevBio
Target Recruit Count
15
Registration Number
NCT06780852
Locations
🇬🇧

Bristol Southmead Hospital, Bristol, United Kingdom

A Pilot Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive

Not Applicable
Active, not recruiting
Conditions
Craniotomy
First Posted Date
2023-10-23
Last Posted Date
2025-07-09
Lead Sponsor
RevBio
Target Recruit Count
20
Registration Number
NCT06095531
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

🇺🇸

Semmes Murphey Clinic, Memphis, Tennessee, United States

Feasibility Study to Assess Outcomes of Immediately Inserted and Restored Dental Implants Using pH-modified Tetranite

Not Applicable
Recruiting
Conditions
Adhesive Dental
First Posted Date
2022-09-10
Last Posted Date
2022-10-26
Lead Sponsor
RevBio
Target Recruit Count
15
Registration Number
NCT05535426
Locations
🇬🇧

Norton Implants, London, United Kingdom

Immediate Placement and Stabilization of Dental Implants With Tetranite Stabilization Material in Mandibular and Maxillary Tooth Extraction Sites That Fail to Provide Adequate Primary Stability

Completed
Conditions
Adhesive Dental
First Posted Date
2019-10-09
Last Posted Date
2024-02-21
Lead Sponsor
RevBio
Target Recruit Count
20
Registration Number
NCT04121364
Locations
🇺🇸

University of Texas Health Science Center - San Antonio, San Antonio, Texas, United States

News

RevBio's Tetranite Bone Adhesive Trial Expanded Following FDA Nod, Gains CMS Reimbursement

RevBio received FDA approval to expand its clinical trial for Tetranite, a bone adhesive biomaterial, after demonstrating safety in initial patients.

© Copyright 2025. All Rights Reserved by MedPath